Russell Investments Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.1M | Sell |
|
|||||
|
2024
Q4 | $2.7M | Sell |
|
|||||
|
2024
Q3 | $3.9M | Sell |
|
|||||
|
2024
Q2 | $4.78M | Buy |
|
|||||
|
2024
Q1 | $3.52M | Buy |
|
|||||
|
2023
Q4 | $1.1M | Buy |
|
|||||
|
2023
Q3 | $403K | Sell |
|
|||||
|
2023
Q2 | $491K | Buy |
|
|||||
|
2023
Q1 | $208K | Buy |
|
|||||
|
2022
Q4 | $201K | Hold |
|
|||||
|
2022
Q3 | $176K | Sell |
|
|||||
|
2022
Q2 | $6.21M | Sell |
|
|||||
|
2022
Q1 | $27.2M | Buy |
|
|||||
|
2021
Q4 | $20M | Sell |
|
|||||
|
2021
Q3 | $14.9M | Buy |
|
|||||
|
2021
Q2 | $11.1M | Buy |
|
|||||
|
2021
Q1 | $323K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $185K | Hold |
|
|||||
|
2020
Q2 | $185K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.99M | Buy |
|
|||||
|
2019
Q3 | $239K | Buy |
|
|||||
|
2019
Q2 | $230K | Buy |
|
|||||
|
2019
Q1 | $135K | Buy |
|
|||||
|
2018
Q4 | $47K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $94K | Sell |
|
|||||
|
2017
Q3 | $101K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $623K | Buy |
|
|||||
|
2016
Q4 | $574K | Buy |
|